Condition: Dravet Syndrome · Sponsor: Longboard Pharmaceuticals
This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DS. The study consists of 3 main phases: Screening, Titration period, and Maintenance period, followed by a Taper period and Follow-Up. Participants will be randomized to LP352 or placebo. The total duration of the study will be approximately 24 months.
This description comes directly from the study's public registry record.
Email contact via H. Lundbeck A/S · +45 36301311 · HQ_Medinfo@Lundbeck.com
Always discuss trial participation with your own doctor first.
| Arkansas Children's Hospital - PIN | Little Rock, Arkansas, United States | Recruiting |
| Children's Hospital Los Angeles - PIN | Los Angeles, California, United States | Recruiting |
| David Geffen School of Medicine at UCLA | Los Angeles, California, United States | Recruiting |
| The Stanford Division of Child Neurology | Palo Alto, California, United States | Recruiting |
| UCSF Children's Hospital | San Francisco, California, United States | Completed |
| Children's Hospital Colorado. | Aurora, Colorado, United States | Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| NW FL Clinical Research Group, LLC | Gulf Breeze, Florida, United States | Recruiting |
| Nicklaus Children's Hospital - PIN | Miami, Florida, United States | Recruiting |
| Research Institute of Orlando LLC | Orlando, Florida, United States | Completed |
| Pediatric Epilepsy and Neurology Specialists | Tampa, Florida, United States | Recruiting |
| Rare Disease Research, LLC - Atlanta - RDR - PIN | Atlanta, Georgia, United States | Completed |
+ 90 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06660394